Drug Type Monoclonal antibody |
Synonyms MSM 608, MSM608 |
Target |
Mechanism GPCR modulators(G-protein coupled receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | US | 30 Jan 2022 |